Hasil Pencarian  ::  Simpan CSV :: Kembali

"The 'Handbook on Injectable Drugs' is the premier reference for compatibility, stability, storage and preparation of parenteral drugs, all peer reviewed with new monographs, new references, additional information and the latest guidelines--essential for your confidence as a professional who makes critical decisions on a daily basis. With a 35-year track record as the industry's 'gold standard,' the 17th Edition is uniquely designed to make complex and thorough data easily accessible to busy practitioners worldwide"

"Now in its fourth edition and with a new title - Injection Techniques in Musculoskeletal Medicine - this step-by-step guide is a resource used by practitioners who have to deal with the management of painful joints and soft tissues, particularly in relation to sports and overuse injuries. Area by area, guidance is given for each lesion on appropriate patient selection and delivery of the drug. Every technique has its own two-page spread containing a written description along with an anatomical illustration of the region and a photograph showing the anatomical landmarks for the injection."

"Buku yang berjudul "New guide to medicines & drugs" ini dipersembahkan oleh The British Medical Association. Buku ini berisikan panduan mengenai obat-obatan."

"ABSTRAKRingkasan penelitian ini membahas tentang kelalaian bidan dan asisten apoteker yang menyebabkan kematian berdasarkan analisis putusan No. 963 K/PID.SUS/2013 Tipe penelitian ini adalah deskriptif, karena penelitian ini menjelaskan permasalahan didasarkan pada teori atau ditinjau kaitannya antara teori dan praktek. Metode penelitian yang digunakan adalah yuridis normatif, yaitu dengan mengacu pada norma hukum yang terdapat pada peraturan Perundang-Undangan dan putusan pengadilan serta norma-norma yang berlaku dan mengikat masyarakat. Penelitian ini menjabarkan tanggung jawab dan kewenangan bidan dan asisten apoteker dalam menjalankan praktek dan dalam pemberian obat serta menganalisis putusan No. 963 K/PID.SUS/2013 Tanggung jawab dan kewenangan bidan dan asisten apoteker baik dalam menjalankan praktek dan dalam pemberian obat telah diatur dengan sangat baik dan merupakan bentuk jaminan keselamatan bagi pasien serta merupakan jaminan keamanan bagi tenaga kesehatan. Baiknya regulasi tersebut juga merupakan bentuk preventif terhadap timbulnya malpraktek atau kelalaian tenaga kesehatan dalam menjalankan tanggung jawab profesinya. Hasil penelitian ini adalah bahwa putusan pengadilan sudah tepat dan sesuai dengan aturan yang berlaku.

---

ABSTRACTThis summary will discuss about midwife and assistant pharmacist inadvertency on drug administration that had caused death based on health law Decision Number 536 PID.B.2010.PN.PDG. The type of this research is descriptive, meaning that the research will describe problems based on theory or by seeing the connection between the theory and the actual reality. The method used in this research is juridical normative, which means that the research is conducted according to the legal norm that is available in the legislation and court decision, also society rsquo s norms. This research explains midwife and pharmacist assistant rsquo s responsibilities and authorities on doing their duty and on drug administration, also gives a good analysis about court decision No. 963 K PID.SUS 2013 Both midwife and pharmacist assistant rsquo s responsibilities and authorities have been regulated so well so they become both form of safety assurance for patients, and form of security assurance for health workers. The good regulation also prevents malpractices on happening when health workers are doing their responsibilities. The result is that the court ruling is proper and is made based the rules applied."

"Penelitian ini bertujuan menilai dan membandingkan efektivitas injeksi subkonjungtiva bevacizumab dosis 5 mg dengan dosis 2.5 mg dalam menurunkan area neovaskularisasi kornea. Sampel adalah dua puluh empat pasien dengan neovaskularisasi kornea oleh karena berbagai etiologi. Pemeriksaan pada sampel dilakukan sebelum, satu minggu setelah injeksi dan empat minggu setelah injeksi yang meliputi penilaian area neovaskularisasi kornea dengan menggunakan image J analysis, pemeriksaan tajam penglihatan tanpa dan dengan koreksi, derajat kekeruhan kornea serta kadar vascular endothelial growth factor (VEGF) air mata. Pada satu minggu dan empat minggu paska injeksi perubahan area neovaskularisasi kornea pada dosis 5 mg (5.21% dan 5.37%) lebih besar dibandingkan dosis 2.5 mg (3.77% dan 4.13%). Hasil yang serupa juga didapatkan pada etiologi non-infeksi dan area neovaskularisasi kornea yang melibatkan lebih dari dua kuadran kornea. Pada keluaran sekunder yaitu tajam penglihatan, derajat kekeruhan kornea dan kadar VEGF air mata di kedua dosis cenderung stabil jika dibandingkan sebelum dan sesudah injeksi. Injeksi subkonjungtiva bevacizumab dosis 5 mg menurunkan area neovaskularisasi kornea lebih banyak dibandingkan dosis 2.5 mg terutama pada etiologi non-infeksi dan keterlibatan kuadran kornea yang meliputi lebih dari dua kuadran.

---

This study aim to assess and compare the effectiveness of subconjunctival bevacizumab injection 5 mg with 2.5 mg in decreasing the area of corneal neovascularization. Samples consist of twenty-four patients with corneal neovascularization due to various etiologies. The examinations were taken at each visit before injection, 1 week after injection and 4 weeks after injection . Changes in neovascularization evaluated by using image J analysis, visual acuity, density of corneal haziness and level of vascular endothelial growth factor (VEGF) in tears were documented every visit. At 1 week and 4 weeks after injection, changes of neovascularization were higher in 5 mg (5.21% and 5.37%) compare to 2.5 mg (3.77% and 4.13%). The same results were also found in non-infection patient and patient involving more than two quadrants cornea. All of the secondary outcomes showed a stable result before and after injection between the two injections dose. Subconjunctival bevacizumab injection 5 mg is more effective in decreasing corneal neovascularization compare to 2.5 mg especially in non-infection patient and patient involving more than two quadrants cornea. "